Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.
about
Fetal programming and early identification of newborns at high risk of free radical-mediated diseasesThe Effect of the Traditional Mediterranean-Style Diet on Metabolic Risk Factors: A Meta-AnalysisSystematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationRed Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction.Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosisPI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndromeHeart of the matter: coronary dysfunction in metabolic syndrome.Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesisChronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure.2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with Type-2 diabetes with different body mass index.Discordances among different tools used to estimate cardiovascular risk in postmenopausal womenEligibility for statin therapy by the JUPITER trial criteria and subsequent mortalityThe role of a dairy fraction rich in milk fat globule membrane in the suppression of postprandial inflammatory markers and bone turnover in obese and overweight adults: an exploratory studyExistence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia.Pharmacotherapy of pediatric metabolic syndromeIdentification and treatment of metabolic complications in pediatric obesity.Serum HDL-C level of Iranian adults: results from sixth national Surveillance of Risk Factors of Non-Communicable Disease.Effects of natural mineral-rich water consumption on the expression of sirtuin 1 and angiogenic factors in the erectile tissue of rats with fructose-induced metabolic syndromeThe association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population.The relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart diseaseThe association between variants on chromosome 9p21 and inflammatory biomarkers in ethnically diverse women with coronary heart disease: a pilot study.Gender differences in insulin resistance, body composition, and energy balance.The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart diseaseCardiometabolic risk in US Army recruits and the effects of basic combat training.Physical activity and cardiovascular risk factors among rural and urban groups and rural-to-urban migrants in Peru: a cross-sectional studyCorrelation between the morning hypertension on ambulatory blood pressure monitoring and the left ventricular mass in childrenDietary energy density: a mediator of depressive symptoms and abdominal obesity or independent predictor of abdominal obesity?The relationship between coronary artery calcification and bone mineral density in patients according to their metabolic syndrome statusGut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulationWeight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study.A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.Effects of metabolic syndrome with or without obesity on outcomes after coronary artery bypass graft. A cohort and 5-year studyIMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic modelRelative utility of 1-h Oral Glucose Tolerance Test as a measure of abnormal glucose homeostasis.Prevalence of metabolic syndrome in the Canadian adult population.Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control studyAssociation of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention StudyAn association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances.Cardiovascular comorbiditiy in psoriasisCardiovascular risk and insulin resistance in childhood cancer survivors.
P2860
Q26750488-10E71302-6BA3-4A4F-8E2D-A03907CB8FFBQ26752983-0E4F6E47-BD5B-4FCE-80AB-58C7DAB1449BQ26774109-3B32FB49-51AA-4B28-906B-C65CEDA8459BQ27345199-CB110A65-8DCC-47A3-945C-33784C8223BAQ28384652-DA876D65-2459-42BC-97EF-AE7909AF6388Q30315106-F4918E31-D24F-4D65-875D-B710B5407C16Q30404992-C2A2C703-8234-44F4-BDB4-F92DC6795030Q30881258-0428EF26-CF07-4019-9062-8AB284AA6E41Q33511547-3E97C1FA-2D91-4090-B3C4-020BD59EF59AQ33582700-0AA260D2-4EF8-432E-BA84-B52EEB946A2EQ33595939-146D6315-862D-4005-890C-B747FC805E68Q33618846-D2E27656-2A21-4983-A8AC-1F6DE20DBDC4Q33702867-52382F98-E093-4560-86DC-CB98B3C51D14Q33820629-659B85A1-A24B-41CE-8DEE-A9295A0F6D57Q33827978-73D17B21-2231-4BC2-B74A-463E4955A1D0Q33893011-C2A1135B-BFA8-43A8-9764-4F75A224F8C1Q33904754-E94806F3-BC69-46E8-B14B-F24160562A0BQ33922444-5400A0C9-33EE-4151-9DEB-A1F366A90835Q33929599-EB1D5BC7-1796-441C-90B5-42E6B2A9B216Q33942212-87BC08D9-CA1C-4729-AC79-BA8FE1F47352Q33986857-72AB666E-167A-43D5-88E5-E61CDDB2B5B6Q34013754-ED27FA08-9639-4D7A-937B-202FEED84B3EQ34033670-6A4E0DFB-7E0C-45D4-80B3-C7AEE633173CQ34181635-54F30488-D29D-4380-B779-65E7C1C0F5EAQ34211762-05B70F08-97DE-4FEF-ABB3-39110CE9DF1AQ34347840-F180309F-AFE9-408B-8663-C9F54D5A42EBQ34495650-9E29C6FC-2524-41A3-AF99-BB039A4E1726Q34648763-99C61C27-7A1C-4E4F-BDA1-7AEE1A54A078Q34669782-2A4C213E-DE64-4AAE-97C3-3EF841B9CA86Q34686210-168D6632-4689-4327-A413-6325414158C6Q35023531-4B262DA5-D0DD-4923-9302-F64C7354D6ACQ35094920-39EBB527-3150-472D-BB9C-3598877A1E34Q35141267-3E97EAC2-7ED1-4A65-8F81-8676D4E56AA7Q35165278-631A68D6-E036-41B6-9868-B347D500D598Q35344135-520B92B3-D3E3-42C1-B9DB-C8D30F8ED368Q35379970-F33C4E56-E9C3-4A9F-B1F0-01DB18ECB2D4Q35389741-F367E119-172C-46BD-9C3F-DCE88ED436BCQ35547285-2787E85C-B173-4AE6-B0C0-5EBE1DC08D96Q35564655-03AF8A93-D6F5-468F-A932-B9EEF08E463CQ35635732-E8C6CDEE-2E7E-4613-99E6-278EFE0A1920
P2860
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Diagnosis and management of th ...... nstitute scientific statement.
@ast
Diagnosis and management of th ...... nstitute scientific statement.
@en
type
label
Diagnosis and management of th ...... nstitute scientific statement.
@ast
Diagnosis and management of th ...... nstitute scientific statement.
@en
prefLabel
Diagnosis and management of th ...... nstitute scientific statement.
@ast
Diagnosis and management of th ...... nstitute scientific statement.
@en
P2093
P1476
Diagnosis and management of th ...... nstitute scientific statement.
@en
P2093
Barry A Franklin
David J Gordon
Fernando Costa
James I Cleeman
Karen A Donato
Peter J Savage
Robert H Eckel
Ronald M Krauss
Scott M Grundy
Stephen R Daniels
P356
10.1097/01.HCO.0000200416.65370.A0
P577
2006-01-01T00:00:00Z